About this trial

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.

Eligibility criteria

Qualifiers

18 or older

able and willing to provide informed consent

diagnosed with CTCL

diagnosed with either atopic dermatitis or eczema

Disqualifiers

Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record

Trial design

Treatments tested in this trial

  • Blood draw, skin biopsy or urine collection

Treatment groups

200 Participants
are divided into 1 treatment group

Locations

1
University of Pittsburgh Medical Center15213, PittsburghPennsylvania, United States

Sponsors and collaborators

University of Pittsburgh

Lead sponsor